Related Experiment Video

Updated: May 21, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Dysregulation of anti-tumor immunity by the matrix metalloproteinase-2

Emmanuelle Godefroy1, Nina Bhardwaj

  • 1New York University Langone Medical Center Cancer Institute; New York, NY, USA.

Oncoimmunology
|June 22, 2012
PubMed

Insights

Matrix metalloproteinase-2 (MMP-2) promotes cancer by altering immune cells. Understanding this mechanism is key to developing new cancer immune therapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Biochemistry

Background:

  • Matrix metalloproteinase-2 (MMP-2) is frequently overexpressed in various cancers.
  • Tumor-associated immune responses can hinder effective cancer treatment.
  • Understanding immune-modulating mechanisms in cancer is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the role of MMP-2 in shaping the tumor immune microenvironment.
  • To investigate how MMP-2 influences dendritic cell function and polarization.
  • To identify key molecular pathways targeted by MMP-2 in promoting anti-tumor immunity.

Main Methods:

  • Analysis of MMP-2 expression in cancer patient samples.
  • In vitro studies using dendritic cells and cancer cell lines.
  • Assessment of cytokine profiles (e.g., IL-12p70) and cell surface marker expression (e.g., OX40L).
  • Investigation of the interaction between MMP-2 and the type-I IFN receptor (IFNAR1).

Main Results:

  • MMP-2 overexpression was confirmed in most cancers studied.
  • MMP-2 conditioned dendritic cells to overexpress OX40L.
  • MMP-2 led to the downregulation of IL-12p70 production by dendritic cells.
  • Degradation of the type-I IFN receptor (IFNAR1) by MMP-2 was identified as a key mechanism.

Conclusions:

  • MMP-2 contributes to detrimental TH2-skewed immune responses in cancer.
  • MMP-2 promotes immune evasion by altering dendritic cell function via IFNAR1 degradation.
  • Targeting MMP-2 or its downstream effects may offer novel strategies for cancer immunotherapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...